Skip to main content
. 2020 Jul 30;10:12870. doi: 10.1038/s41598-020-69769-3

Table 1.

Demographic, clinical and structural characteristics.

CON (N = 47) MDD (N = 78) Statistics p Effect size
Female, N (%) 26 (55.3%) 56 (71.8%) x2 = 3.53 0.06
Age, M (SD) 14.3 (1.4) 14.9 (1.5) t = 2.23  < .05 Cohen’s d = 0.41
Intelligence quotient (IQ), M (SD) 109.6 (10.7) 105.3 (13.9) t = 1.95 0.07
Depressive symptoms (CDRS-R), M (SD) 22.7 (4.4) 58.8 (11.7) F = 367.8a  < .001 Partial η2= 0.75
Anxiety symptoms (SCARED), M (SD)c 10.7 (10.1) 36.7 (16.2) F = 98.60a  < .001 Partial η2= 0.45
Peer problems (PVS/BBS), M (SD) 3.2 (0.7) 4.1 (1.1) F = 24.53a < .001 Partial η2= 0.17
Subcortical volumes (mm3)
Amygdala, M (SD) 3,298.3 (345.5) 3,270.0 (369.1) F = 0.22b 0.64
Hippocampus, M (SD) 8,167.0 (627.1) 8,266.2 (741.2) F = 1.28b 0.26
NAcc, M (SD) 878.3 (110.2) 945.0 (134.3) F = 10.81b  < .005 Partial η2= 0.08
Intracranial volume, M (SD) 1,519,375.6 (128,157.7) 1,532,970.3 (140,467.0) t = 0.54 0.59

CON healthy controls, MDD major depressive disorder, CDRS-R children’s depression rating scale-revised, SCARED the screen for child anxiety related emotional disorders, PVS/BBS peer-vicitmization scale/bullying-behavior scale, NAcc nucleus accumbens, M mean, SD standardized deviation.

aAdjusted for gender, age, and IQ.

bAdjsuted for gender, age, IQ, and intracranial volume (ICV).

cOne outlier in the CON group was identified and removed.